Andrea S. Blevins Primeau, PhD, MBA

Researchers sought to determine whether patients with lymphoma receiving anticancer therapy had responses to COVID-19 vaccination.

Researchers found a significant increase in the risk of breast cancer among men who had not fathered any children.

Researchers sought to determine whether tisagenlecleucel is safe and effective in patients younger than 3 years old with relapsed/refractory ALL.

Researchers sought to determine whether allo-HSCT would be helpful in treating patients with hepatosplenic T-cell lymphoma.

Overall survival was longer with ablative radiotherapy than with conventional radiotherapy.

Researchers sought to determine whether levels of different DNA demethylation intermediates would be associated with AML or MDS.

Researchers sought to determine whether treatment of CD30-positive lymphomas with an innate cell engager would be effective.